FMP

FMP

Blogs by Gordon Thompson

blog post title

Market Losers: Analyzing the Downturns

The market has recently seen significant shifts, with several companies experiencing notable price declines. These movements reflect a mix of sector-specific challenges and broader economic conditions...

blog post title

Fiverr International Ltd (NYSE: FVRR) Targets Growth with AI Integration and Restructuring

Fiverr International Ltd (NYSE: FVRR) is a prominent online services marketplace that connects freelancers with business...

blog post title

Kopin Corporation's Stock Upgrade and Performance Analysis

Kopin Corporation, listed on NASDAQ as KOPN, specializes in application-specific optical systems and high-performance mi...

blog post title

aTyr Pharma, Inc. (NASDAQ:ATYR) Downgraded by RBC Capital

aTyr Pharma, Inc. (NASDAQ:ATYR) is a biotechnology company focused on developing innovative medicines for patients with ...

blog post title

Champions Oncology, Inc. (NASDAQ: CSBR) Surpasses Earnings Expectations in Q1 2026

Champions Oncology, Inc. (NASDAQ: CSBR) is a key player in the field of translational oncology research. The company foc...

blog post title

Allstate Corporation (NYSE:ALL) Coverage Initiated with Bullish Outlook

Allstate Corporation (NYSE:ALL) is a prominent player in the insurance industry, offering a wide range of products inclu...

blog post title

aTyr Pharma, Inc. (NASDAQ:ATYR) Faces Market Challenges Despite Promising Developments

aTyr Pharma, Inc. (NASDAQ:ATYR) is a biotechnology company focused on developing innovative medicines for patients with ...

blog post title

Delcath Systems, Inc. (NASDAQ:DCTH) Financial Performance and Competitive Landscape

Delcath Systems, Inc. (NASDAQ:DCTH) is a medical technology company focused on oncology. It develops and commercializes ...

blog post title

Nu Holdings Ltd. (NYSE:NU) Financial Efficiency Analysis

Nu Holdings Ltd. (NYSE:NU) is a prominent digital banking platform in Latin America, offering a range of financial servi...

blog post title

Nektar Therapeutics' Financial Performance Raises Concerns

Nektar Therapeutics (NASDAQ:NKTR) is a biopharmaceutical company that focuses on developing innovative medicines in area...